Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Magnus Gisslen

Professor/ chief physician

Magnus Gisslen
Professor/ chief physician
magnus.gisslen@infect.gu.se

Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: Östra sjukhuset , Göteborg


Department of Infectious Diseases at Institute of Biomedicine (More Information)
Box 480
405 30 Göteborg
0313421000
Visiting Address: Guldhedsgatan 10 A-B , 413 46 Göteborg

Latest publications

Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders.
Aylin Yilmaz, Dietmar Fuchs, Richard W Price, Serena Spudich, Kaj Blennow et al.
Current HIV/AIDS reports, Review article 2019
Review article

CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection
Magnus Gisslén, Amanda Heslegrave, E. Veleva, A. Yilmaz, L. M. Andersson et al.
Neurology-Neuroimmunology & Neuroinflammation, Journal article 2019
Journal article

Elevated cerebrospinal fluid Galectin-9 is associated with central nervous system immune activation and poor cognitive performance in older HIV-infected individuals.
Thomas A Premeaux, Michelle L D'Antoni, Mohamed Abdel-Mohsen, Satish K Pillai, Kalpana J Kallianpur et al.
Journal of neurovirology, Journal article 2018
Journal article

HIV-1 RNA Detected in the CNS after Years of Suppressive Antiretroviral Therapy Can Originate from a Replicating CNS Reservoir or Clonally Expanded Cells.
Sarah B Joseph, Laura P Kincer, Natalie M Bowman, Chris Evans, Michael J Vinikoor et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Journal article 2018
Journal article

Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy.
Albert M Anderson, Kirk A Easley, Nicole Kasher, Donald Franklin, Robert K Heaton et al.
Journal of neurovirology, Journal article 2018
Journal article

Showing 71 - 80 of 165

2012

Low Prevalence of Transmitted Drug Resistance in Patients Newly Diagnosed with HIV-1 Infection in Sweden 2003-2010.
Annika Karlsson, Per Björkman, Göran Bratt, Håkan Ekvall, Magnus Gisslén et al.
PloS one, Journal article 2012
Journal article

Antiretroviral drug treatment of CNS HIV-1 infection.
Aylin Yilmaz, Richard W Price, Magnus Gisslén
The Journal of antimicrobial chemotherapy, Journal article 2012
Journal article

2011

Non-linear mixed effects modeling of antiretroviral drug response after administration of lopinavir, atazanavir and efavirenz containing regimens to treatment-naïve HIV-1 infected patients.
Daniel Röshammar, Ulrika S H Simonsson, Håkan Ekvall, Leo Flamholc, Vidar Ormaasen et al.
Journal of pharmacokinetics and pharmacodynamics, Journal article 2011
Journal article

Reply to Seligman
Arvid Edén, Magnus Gisslén, Lars Hagberg, Bo Svennerholm, Serena Spudich et al.
J Infect Dis , Magazine article 2011
Magazine article

Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish recommendations 2010.
Lars Navér, Jan Albert, Erik Belfrage, Leo Flamholc, Magnus Gisslén et al.
Scandinavian journal of infectious diseases, Journal article 2011
Journal article

Bilirubin-a potential marker of drug exposure in atazanavir-based antiretroviral therapy.
Dinko Rekić, Oskar Clewe, Daniel Röshammar, Leo Flamholc, Anders Sönnerborg et al.
The AAPS journal, Journal article 2011
Journal article

Showing 71 - 80 of 165

Page Manager: Chatrine Butler|Last update: 8/28/2017
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?